A detailed history of First Hawaiian Bank transactions in Novartis Ag stock. As of the latest transaction made, First Hawaiian Bank holds 20,796 shares of NVS stock, worth $2.02 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
20,796
Previous 21,729 4.29%
Holding current value
$2.02 Million
Previous $2.31 Million 3.37%
% of portfolio
0.08%
Previous 0.08%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$106.13 - $120.89 $99,019 - $112,790
-933 Reduced 4.29%
20,796 $2.39 Million
Q2 2024

Jul 02, 2024

SELL
$92.57 - $107.37 $76,185 - $88,365
-823 Reduced 3.65%
21,729 $2.31 Million
Q1 2024

Apr 05, 2024

BUY
$95.27 - $108.47 $43,633 - $49,679
458 Added 2.07%
22,552 $2.18 Million
Q4 2023

Jan 08, 2024

SELL
$92.27 - $101.54 $465,133 - $511,863
-5,041 Reduced 18.58%
22,094 $2.23 Million
Q3 2023

Oct 10, 2023

BUY
$94.73 - $105.13 $5,115 - $5,677
54 Added 0.2%
27,135 $2.76 Million
Q2 2023

Jul 06, 2023

SELL
$92.52 - $104.91 $625,620 - $709,401
-6,762 Reduced 19.98%
27,081 $2.73 Million
Q1 2023

Apr 18, 2023

SELL
$80.03 - $92.81 $100,357 - $116,383
-1,254 Reduced 3.57%
33,843 $3.11 Million
Q4 2022

Jan 12, 2023

SELL
$75.55 - $92.52 $42,081 - $51,533
-557 Reduced 1.56%
35,097 $3.18 Million
Q3 2022

Oct 05, 2022

SELL
$74.61 - $87.26 $286,203 - $334,729
-3,836 Reduced 9.71%
35,654 $2.71 Million
Q2 2022

Jul 22, 2022

SELL
$80.52 - $93.75 $600,920 - $699,656
-7,463 Reduced 15.89%
39,490 $3.34 Million
Q1 2022

Apr 06, 2022

SELL
$80.11 - $90.62 $76,665 - $86,723
-957 Reduced 2.0%
46,953 $4.12 Million
Q4 2021

Jan 12, 2022

BUY
$79.7 - $88.13 $3.08 Million - $3.41 Million
38,650 Added 417.39%
47,910 $4.19 Million
Q3 2021

Oct 12, 2021

SELL
$81.78 - $95.14 $126,595 - $147,276
-1,548 Reduced 14.32%
9,260 $758,000
Q2 2021

Jul 08, 2021

BUY
$85.24 - $94.15 $12,700 - $14,028
149 Added 1.4%
10,808 $986,000
Q1 2021

Apr 09, 2021

BUY
$83.5 - $98.47 $29,308 - $34,562
351 Added 3.41%
10,659 $912,000
Q4 2020

Jan 12, 2021

SELL
$78.07 - $94.43 $6,401 - $7,743
-82 Reduced 0.79%
10,308 $973,000
Q3 2020

Oct 06, 2020

SELL
$82.14 - $91.0 $31,870 - $35,308
-388 Reduced 3.6%
10,390 $903,000
Q2 2020

Aug 05, 2020

BUY
$80.93 - $91.1 $146,564 - $164,982
1,811 Added 20.2%
10,778 $942,000
Q1 2020

Apr 21, 2020

BUY
$70.67 - $99.01 $131,304 - $183,960
1,858 Added 26.14%
8,967 $739,000
Q4 2019

Jan 13, 2020

BUY
$84.35 - $95.37 $9,531 - $10,776
113 Added 1.62%
7,109 $674,000
Q3 2019

Oct 03, 2019

SELL
$85.54 - $94.26 $213,080 - $234,801
-2,491 Reduced 26.26%
6,996 $608,000
Q2 2019

Jul 15, 2019

SELL
$75.4 - $92.8 $201,544 - $248,054
-2,673 Reduced 21.98%
9,487 $867,000
Q1 2019

Apr 02, 2019

SELL
$75.32 - $86.15 $35,475 - $40,576
-471 Reduced 3.73%
12,160 $1.17 Million
Q4 2018

Jan 11, 2019

BUY
$73.66 - $82.02 $139,143 - $154,935
1,889 Added 17.59%
12,631 $1.08 Million
Q3 2018

Oct 16, 2018

BUY
$66.94 - $77.43 $719,069 - $831,753
10,742 New
10,742 $926,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track First Hawaiian Bank Portfolio

Follow First Hawaiian Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.